Mirahype S 50/5 Tablet ER

Mirahype S 50/5 Tablet ER
Mirabegron (50mg) + Solifenacin (5mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Mirahype S 50/5 Tablet ER is a once-daily, extended-release formulation containing mirabegron (50mg) and solifenacin (5mg), a combination therapy for the treatment of overactive bladder (OAB) with symptoms of urinary frequency, urgency, and incontinence. This product is designed to provide sustained release of its active ingredients, mirabegron and solifenacin, over an extended period, allowing for consistent and reliable therapeutic effects. Mirabegron, a β3-adrenoceptor agonist, increases urinary bladder capacity and reduces urgency, while solifenacin, a muscarinic receptor antagonist, reduces the frequency of bladder contractions and urinary incontinence episodes. The combination of these two compounds synergistically works together to provide enhanced relief from OAB symptoms. Mirahype S 50/5 Tablet ER is indicated for patients who have not responded adequately to previous therapy or who have intolerable side effects. This product is contraindicated in patients with known hypersensitivity to either mirabegron or solifenacin, and caution should be exercised in patients with moderate to severe renal impairment.
Active composition
Solifenacin 5 mg
+1 more active ingredient
About Solifenacin
Solifenacin is an antimuscarinic agent used to treat overactive bladder symptoms. It works by relaxing bladder muscles and reducing urgency. Solifenacin's clinical significance lies in its ability to improve bladder control. In summary, Solifenacin is beneficial for managing urinary incontinence.
How It Works
Solifenacin antagonizes muscarinic receptors in the bladder, reducing detrusor muscle contractions and increasing bladder capacity.
All Active Ingredients
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Information regarding the use of Mirahype S 50/5 Tablet ER during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Mirahype S 50/5 Tablet ER during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
There is limited information available on the use of Mirahype S 50/5 Tablet ER in patients with kidney disease. Please consult your doctor.
Exercise Caution
Breastfeeding
It is not known whether Mirahype S 50/5 Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
There is limited information available on the use of Mirahype S 50/5 Tablet ER in patients with liver disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Mirahype S 50/5 Tablet ER







